Andrew F. Stewart
Works at
Icahn School of Medicine at Mount Sinai
Director, diabetes and bone disease
Sources: reporter.nih.gov
Grants and prizes
National Institute of Diabetes and Digestive and Kidney Diseases
R01, DYRK Inhibitors for Human Beta Cell Expansion, R01DK105015, 2016–2025, 20 May 2024
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Phase 1 Translational Diabetes Research Using The DYRK1A inhibitor, Harmine, R01DK128242, 2022–2024, 1 Aug 2023
National Institute of Diabetes and Digestive and Kidney Diseases
R01, Biological and Medicinal Chemistry Approaches to Human Beta Cell Regeneration, R01DK125285, 2020–2024, 23 Mar 2023
Sources: reporter.nih.gov